Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy

Cell Reports(2024)10.1016/j.celrep.2024.114875Source: DataRank Database

Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy is a research paper published in Cell Reports (2024). On theSindex it has a DataRank of 0.539. It has been cited 14 times, with 11 citing works in its 1-hop citation network.

N/A

0.539DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access14 citations · 11 citing works in its network

Download PDF

Cite:

Linked data & code

geo gen uniprot

Data availability

Repositories this paper deposited data in (declared in PubMed).

GEOGSE276902 GSE276904

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 2.22)OA: goldTopics (83)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 75%Citation Network 25%

Base Score Contribution

0.406

From this paper's citation signal

Citation Network Contribution

0.133

From 9 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 11 citers.

Computational neoantigen prediction for cancer immunotherapy
Genes and Immunity20255 citations58 referencesContributes 0.031
Harnessing adjuvant-induced epigenetic modulation for enhanced immunity in vaccines and cancer therapy
Frontiers in Immunology20254 citations61 referencesContributes 0.026
TREM2-mediated regulation of myeloid cells in the tumor microenvironment: new insights and therapeutic prospects
npj Precision Oncology202515 citations111 referencesContributes 0.025
Neoantigen vaccines: advancing personalized cancer immunotherapy
Exploration of Immunology202514 citations152 referencesContributes 0.018
Advances in Peptide‐Based Cancer Vaccines: Materials, Targeting, and Delivery Strategies
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology20252 citations64 referencesContributes 0.017

Authors (17)

Alexander S. Shavkunov ORCID,Qi Miao ORCID,Akata Saha ORCID,Tomoyuki Minowa ORCID,Martina Molgora ORCID

Live enrichment

PubMed:39446585 PMC:PMC11785356 OpenAlex:https://openalex.org/W4403679484

Cancer Prevention and Research Institute of Texas

Grant: RR190017

National Cancer Institute

Grant: R01CA282027

National Cancer Institute

Grant: P30CA016672

National Cancer Institute

Grant: U01CA247760

National Cancer Institute

Grant: RP210028

National Institutes of Health

Grant: P50CA221703

National Institutes of Health

Grant: R01CA262684

National Institutes of Health

Grant: 5P50CA221703-04

The University of Texas MD Anderson Cancer Center SPORE in Melanoma

National Institutes of Health

Grant: 5R01CA262684-02

Targeting TREM2 to boost anti-cancer therapy

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

National Institutes of Health

Grant: 5R01CA282027-02

Bhlhe40 Regulation of T Cell Function During Cancer Immunotherapy

National Institutes of Health

Grant: 5U01CA247760-02

Informatics for Functional Integration of Heterogeneous Cancer Genome and Transcriptome Sequencing Data

V Foundation for Cancer Research

University of Texas MD Anderson Cancer Center

Parker Institute for Cancer Immunotherapy

Fondazione Internazionale Premio Balzan

FWCI

2.22

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.celrep.2024.114875

publisherhttps://doi.org/10.1016/j.celrep.2024.114875

publisherhttps://api.elsevier.com/content/article/PII:S2211124724012269?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124724012269?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39446585

Fields of Study

Immunotherapy and Immune ResponsesImmune Cell Function and Interactioninterferon and immune responses0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsCancer VaccinesReceptors, ImmunologicMacrophagesMiceImmune Checkpoint InhibitorsCD8-Positive T-LymphocytesAntigens, NeoplasmMice, Inbred C57BLMembrane GlycoproteinsFemaleHumansCTLA-4 AntigenImmunotherapyProgrammed Cell Death 1 ReceptorMannose ReceptorCell Line, Tumor

MeSH Terms

Immune Checkpoint InhibitorsMannose ReceptorAnimalsAntigens, NeoplasmFemaleHumansImmunotherapyMacrophagesMembrane GlycoproteinsMice, Inbred C57BLReceptors, ImmunologicCD8-Positive T-LymphocytesCancer VaccinesCell Line, TumorMiceCTLA-4 AntigenProgrammed Cell Death 1 Receptor

Keywords

Cancer therapyMedicineImmunologyMacrophageCancerImmune systemImmune checkpointTargeted therapyImmunotherapyCancer researchBiologyInternal medicineCancer ImmunotherapyTumor MicroenvironmentCombination ImmunotherapyCd4 T CellsTrem2Immune Checkpoint TherapyCp: ImmunologyCp: CancerNeoantigen Cancer VaccinesNeoantigen-specific Cd8 T CellsAnti-ctla-4/anti-pd-1Intratumoral MacrophagesMembrane GlycoproteinsQH301-705.5MacrophagesProgrammed Cell Death 1 ReceptorCD8-Positive T-LymphocytesCancer VaccinesArticleMice, Inbred C57BLMiceAntigens, NeoplasmCell Line, TumorAnimalsHumansFemaleCTLA-4 AntigenBiology (General)Receptors, ImmunologicImmune Checkpoint InhibitorsMannose Receptor

Sustainable Development Goals

SDG 0: Good health and well-being